NCT06323980 is a NA clinical trial of Reverse Total Shoulder in Arthroplasty, sponsored by DePuy Orthopaedics.

Who is sponsoring NCT06323980?

NCT06323980 is sponsored by DePuy Orthopaedics.

What drugs are being tested in NCT06323980?

Interventions in NCT06323980: Reverse Total Shoulder.

What condition does NCT06323980 study?

NCT06323980 studies Arthroplasty, Replacement, Shoulder.

Is NCT06323980 still recruiting?

NCT06323980 is currently recruiting now. Last updated 13 April 2026.

Last reviewed 2026-04-13 · How we verify

NCT06323980

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

INHANCE Stemless Reverse Shoulder IDE

Recruiting now NA Last updated 13 April 2026

What this trial tests

NA trial testing Reverse Total Shoulder in Arthroplasty in 168 participants. Currently enrolling.

Timeline

4 March 2025

Primary endpoint
10 November 2027

29 September 2028

Quick facts

Lead sponsor	DePuy Orthopaedics
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	168
Start date	4 March 2025
Primary completion	10 November 2027
Estimated completion	29 September 2028
Sites	19 locations across United States

Drugs / interventions tested

Reverse Total Shoulder

Conditions studied

Arthroplasty — all drugs for Arthroplasty →
Replacement — all drugs for Replacement →
Shoulder — all drugs for Shoulder →

Sponsor

DePuy Orthopaedics — full company profile →

Who can join

22 and older, any sex, with Arthroplasty or Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

2:1 Randomized, Controlled, Multi-Center, Prospective, Pre-Market Study of the INHANCE Stemless Reverse Cementless Total Shoulder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Arthroplasty

Currently open trials in the same condition.

NCT07425457 — Cryoneurolysis Prior to Total Knee Arthroplasty (CRYO-TKA Trial) · NA · recruiting
NCT04848896 — Study to Evaluate the Safety and Effectiveness of the REAL INTELLIGENCE™ CORI™ in Total Knee Arthroplasty (TKA) Procedur · NA · recruiting
NCT04849884 — To Evaluate the Performance of the CORI™ KNEE TENSIONER as an Accessory to the CORI™ Surgical System. · NA · active not recruiting
NCT05190666 — Healthy Living After Knee Replacement · NA · active not recruiting

Other DePuy Orthopaedics trials

Trials by the same sponsor.

NCT06631638 — EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)) · NA · recruiting
NCT05357664 — PINNACLE® DM RSA Study · NA · terminated
NCT04630262 — ATTUNE Cementless FB Tibial Base Clinical Study · NA · terminated
NCT04730271 — Comparison of Alignment Achieved Using the VELYS Robotic-Assisted Solution Versus Manual Instrumentation in Total Knee A · NA · completed
NCT04191733 — Anterior Advantage With KINCISE · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06323980 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by DePuy Orthopaedics
Last refreshed: 13 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06323980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing